Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program [0.03%]
美国军事医疗系统乳腺癌患者生存率与SEER数据库的比较研究
Jie Lin,Hai Hu,Craig D Shriver et al.
Jie Lin et al.
Introduction: Accessibility to health care is important to cancer survival. The U.S. military health system (MHS) provides universal health care access. However, whether the universal care has been translated into improve...
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India [0.03%]
UJVIRA(ZRC-3256，曲妥珠单抗_emtansine)与Kadcyla(曲妥珠单抗_emtansine)在治疗HER2阳性转移性乳腺癌疗效、安全、药代动力学和免疫原性的比较：印度多中心开放标签随机试验
Satheesh Chiradoni Thungappa,Tanveer Maksud,Nirmal Raut et al.
Satheesh Chiradoni Thungappa et al.
Background: UJVIRA is the first DCGI approved biosimilar of trastuzumab emtansine (Kadcyla) which may offer an alternative cost-effective treatment option for human epidermal growth factor receptor 2 (HER2)-positive metas...
Clinical Trial
Clinical breast cancer. 2022 Jun;22(4):300-307. DOI:10.1016/j.clbc.2021.11.006 2022
Primary Care Physicians' Perspectives in Leading Breast Cancer Follow-Up Care [0.03%]
乳腺癌随访护理中的初级保健医生视角
Fernando A Angarita,Nicole Jedrzejko,David Eisen et al.
Fernando A Angarita et al.
Introduction: Limited data exist on the barriers associated with transitioning breast cancer follow-up care to primary care physicians (PCPs). This study aimed to describe the current perspectives of PCPs in managing brea...
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients [0.03%]
降级分次乳腺全乳照射不加量的毒性及皮肤晚期反应的时间进程：一项针对大量早期乳腺癌患者的研究
Andrei Fodor,Chiara Brombin,Paola Mangili et al.
Andrei Fodor et al.
Aim: To report toxicity of hypofractionated whole-breast radiotherapy in a large cohort of early-stage breast cancer (BCaients. Materials and methods: ...
Samyukta Mullangi,Neil Vasan
Samyukta Mullangi
De novo metastatic breast cancer (dnMBC) represents a minority of MBC cases, and as such, its genomics are poorly understood. Characterizing the genomics of dnMBC represents an opportunity to delineate metastatic drivers in the absence of t...
Gender Differences in Recommended Treatment Decisions among Breast Cancer Patients: A Study Using the National Cancer Database [0.03%]
基于全国癌症数据库的乳腺癌患者治疗决策性别差异研究
Shamim Shahi,Jane Meza,Pavankumar Tandra et al.
Shamim Shahi et al.
Background: Previous studies have explored surgery refusal among female breast cancer patients. However, little attention has been given to other therapies in both females and males. The goal of this study was to determin...
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay [0.03%]
通过CNSide™试验鉴定脑脊液中的肿瘤细胞诊断乳腺癌女性患者脑膜转移病灶
Margaux Wooster,Julia E McGuinness,Kathleen M Fenn et al.
Margaux Wooster et al.
Introduction: Diagnosis of LM is limited by low sensitivity of cerebrospinal fluid (CSF) cytopathology. Detecting tumor cells in CSF (CSF-TCs) might be more sensitive. We evaluated if CNSide (CNSide), a novel assay for tu...
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC) [0.03%]
RO4929097（一种γ-分泌酶抑制剂）联合阿那曲唑治疗ER阳性转移性乳腺癌患者的Ib期剂量递增试验
Julie A Means-Powell,Ingrid A Mayer,Roohi Ismail-Khan et al.
Julie A Means-Powell et al.
PRECLINICAL STUDIES: have demonstrated a complex cross-talk between Notch and estrogen signaling in ERα-positive breast cancer. Gamma-secretase inhibitors (GSIs) are investigational agents that block the cleavage and activation of Notch re...
Clinical Trial
Clinical breast cancer. 2022 Feb;22(2):103-114. DOI:10.1016/j.clbc.2021.10.013 2022
Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States [0.03%]
中美乳腺癌患者21基因复发评分检测的分布、化疗使用及其预后差异分析
Guan-Qiao Li,Jia Yao,Ping Zhou et al.
Guan-Qiao Li et al.
Purpose: To compare the distribution, chemotherapy-decision making, and prognosis of the 21-gene recurrence score (RS) between Chinese breast cancer (BC) in the United States and White American (WA) BC. ...
Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study [0.03%]
基于乳腺MRI和临床病理特征预测早期浸润性乳腺癌患者腋窝淋巴结转移的诺模图：一项回顾性研究
Mei Xue,Shunan Che,Yuan Tian et al.
Mei Xue et al.
Introduction: To establish a nomogram for predicting axillary lymph node (ALN) involvement in patients with early-stage invasive breast cancer (BC) based on magnetic resonance imaging (MRI) features and clinicopathologica...